Novartis officer proposes $933K share sale

Acquisition entries identify restricted stock vesting between January 20, 2024, and January 29, 2026, as the source of the securities.

Rhea-AI Filing Summary

NOVARTIS AG officer Victor Bulto Carulla reported a proposed sale of 6,000 American Depositary Shares. The notice lists an aggregate market value of $933,180.00, Fidelity Brokerage Services LLC as broker, and NYSE as the exchange. Acquisition entries identify restricted stock vesting, with dates ranging from January 20, 2024, to January 29, 2026.

Key Figures

American Depositary Shares proposed for sale: 6,000 American Depositary Shares Aggregate market value: $933,180.00 ADS in acquisition entry: 61 American Depositary Shares +4 more

7 metrics

American Depositary Shares proposed for sale 6,000 American Depositary Shares Proposed sale by Victor Bulto Carulla

Aggregate market value $933,180.00 American Depositary Shares proposed for sale

ADS in acquisition entry 61 American Depositary Shares January 20, 2024; restricted stock vesting

ADS in acquisition entry 326 American Depositary Shares January 25, 2024; restricted stock vesting

ADS in acquisition entry 638 American Depositary Shares January 25, 2025; restricted stock vesting

ADS in acquisition entry 209 American Depositary Shares January 26, 2025; restricted stock vesting

ADS in acquisition entry 4,766 American Depositary Shares January 29, 2026; restricted stock vesting

Key Terms

American Depositary Shares, Restricted Stock Vesting, Rule 144

3 terms

American Depositary Shares financial

"American Depositary Shares to be sold"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Restricted Stock Vesting financial

"Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NVS American Depositary Shares does Victor Bulto Carulla plan to sell?

Victor Bulto Carulla's proposed sale lists 6,000 American Depositary Shares with an aggregate market value of $933,180.00.

What acquisition history is listed for Victor Bulto Carulla's NVS ADS?

The acquisition entries list 61 American Depositary Shares on January 20, 2024; 326 on January 25, 2024; 638 on January 25, 2025; 209 on January 26, 2025; and 4,766 on January 29, 2026. Each entry identifies restricted stock vesting and compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/28/2026 - 10:47 AM EDT Accepted by SEC EDGAR 10/28/2026 - 10:46 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002098937
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NOVARTIS AG
SEC File Number	001-15024
Address of Issuer	LICHTSTRASSE 35 BASEL SWITZERLAND CH 4056
Phone	01141613241111
Name of Person for Whose Account the Securities are To Be Sold	Bulto Carulla Victor
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6000	933180.00	1908151679	10/28/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
American Depositary Shares	01/20/2024	Restricted Stock Vesting	Issuer			61	01/20/2024	Compensation
American Depositary Shares	01/25/2024	Restricted Stock Vesting	Issuer			326	01/25/2024	Compensation
American Depositary Shares	01/25/2025	Restricted Stock Vesting	Issuer			638	01/25/2025	Compensation
American Depositary Shares	01/26/2025	Restricted Stock Vesting	Issuer			209	01/26/2025	Compensation
American Depositary Shares	01/29/2026	Restricted Stock Vesting	Issuer			4766	01/29/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	10/28/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Victor Bulto Carulla
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)